Home » Repros Announces That Proellex Reduced Pain in Phase 2 Clinical Trial
Repros Announces That Proellex Reduced Pain in Phase 2 Clinical Trial
Repros Therapeutics Inc. released positive results of its recently completed U.S. Phase 2 Proellex endometriosis trial. Proellex is an oral progesterone receptor modulator.
The Earth Times
The Earth Times
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May